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Abstract
Chronic exposure to stress has been widely implicated in the development of anxiety disorders, yet relatively little is known
about the long-term effects of chronic stress on amygdala-dependent memory formation. Here, we examined the effects of
a history of chronic exposure to the stress-associated adrenal steroid corticosterone (CORT) on the consolidation of a fear
memory and the expression of memory-related immediate early genes (IEGs) in the lateral nucleus of the amygdala (LA).
Rats received chronic exposure to CORT (50 mg/ml) in their drinking water for 2 weeks and were then titrated off the CORT
for an additional 6 days followed by a 2 week ‘wash-out’ period consisting of access to plain water. Rats were then either
sacrificed to examine the expression of memory-related IEG expression in the LA or given auditory Pavlovian fear
conditioning. We show that chronic exposure to CORT leads to a persistent elevation in the expression of the IEGs Arc/
Arg3.1 and Egr-1 in the LA. Further, we show that rats with a history of chronic CORT exposure exhibit enhanced
consolidation of a fear memory; short-term memory (STM) is not affected, while long-term memory (LTM) is significantly
enhanced. Treatment with the selective serotonin reuptake inhibitor (SSRI) fluoxetine following the chronic CORT exposure
period was observed to effectively reverse both the persistent CORT-related increases in memory-related IEG expression in
the LA and the CORT-related enhancement in fear memory consolidation. Our findings suggest that chronic exposure to
CORT can regulate memory-related IEG expression and fear memory consolidation processes in the LA in a long-lasting
manner and that treatment with fluoxetine can reverse these effects.
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Introduction
Stress has been strongly implicated in the development of
numerous psychiatric disorders, including post-traumatic stress
disorder (PTSD), an anxiety disorder characterized by intense
fearful memory formation to cues associated with a traumatic
event [1-4]. It is well established that the lateral nucleus of the
amygdala (LA) is a critical region for the formation and storage of
Pavlovian fear memories [5]. It is also known that the LA contains
a rich supply of glucocorticoid receptors which bind glucocorti-
coids released in response to stressful stimuli [6,7], rendering this
brain region a prime target for the site of action of stress-induced
modulation of fear memories [8].
Prolonged periods of stress or chronic exposure to glucocorti-
coids, including the adrenal steroid corticosterone (CORT), have
been observed to promote multiple morphological and molecular
alterations in brain regions associated with cognition and emotion.
In rodent models, for example, prolonged exposure to stress or
oral CORT has been shown to promote dendritic atrophy in the
hippocampus, particularly in area CA3 [9–13], impair hippocam-
pal neurogenesis [14–16], and significantly decrease the expression
of several plasticity-related signaling proteins and genes in the
hippocampus, including the activity of the extracellular signal-
regulated kinase (ERK) and the cAMP-response element binding
protein (CREB) and the expression of brain derived neurotrophic
factor (BDNF) [17–21]. At a functional level, prolonged exposure
to stress or oral CORT in rats has been shown to impair
hippocampal synaptic plasticity [22,23] and hippocampal-depen-
dent memory formation [11,23–26].
A remarkably different picture has emerged in the amygdala
following prolonged exposure to chronic stress. In contrast to the
hippocampus, exposure to chronic stress has been observed to
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promote dendritic hypertrophy in LA neurons [13,27], increase
dendritic spine density [28,29] and to significantly increase the
expression of BDNF [21]. These observations are consistent with
the findings that a bout of chronic stress exposure can promote
anxiety-like behavior in rats [27,30] and enhance the formation of
a Pavlovian fear memory when rats are trained and tested shortly
after the stress exposure period [31,32]. Further, one of the more
notable, and perhaps clinically consequential, aspects of the effects
of chronic stress on the amygdala is the persistence of its
morphological and behavioral effects [8]. It is well established
that the morphological and behavioral effects of chronic stress are
reversible in the hippocampus following a period of recovery
[21,26,27,31]. In contrast, chronic stress has been shown to lead to
persistent dendritic hypertrophy in LA neurons, a persistent
increase in the expression of BDNF mRNA in the LA and
persistent changes in anxiety-like behavior in rats that does not
recover with time [21,27].
Given the persistence of the effects of stress in the amygdala, it is
surprising that few studies have systematically examined the long-
term effects of chronic stress on amygdala-dependent memory
formation. To that end, in the present study we examined the
long-term effects of chronic exposure to oral CORT on the
expression on plasticity-related signaling pathways and memory-
related IEGs in the LA and on the consolidation of a Pavlovian
fear memory. We show that chronic oral CORT exposure
persistently elevates the expression of memory-related IEGs in
the LA and enhances the consolidation of an auditory fear
memory. Further, we show that each of these effects can be
reversed following treatment with the selective serotonin-reuptake
inhibitor (SSRI) fluoxetine. Collectively, our findings suggest that
chronic stress, as modeled by a chronic oral CORT paradigm,
leads to long-lasting alterations in amygdala-dependent learning
and memory processes via alterations in memory-related genes in
LA neurons, findings which may have relevance for understanding
the neurobiological mechanisms underlying the development of
psychiatric disorders such as PTSD that are characterized by
unusually strong and persistent fear memories.
Materials and Methods
Subjects
Adult male Sprague-Dawley rats (Harlan), obtained at ,3
months of age, were housed individually in plastic cages and
maintained on a 12:12 hr light/dark cycle. Food and water were
provided ad libitum throughout the experiments. All procedures
were conducted under the guidelines provided in the National
Institutes of Health Guide for the Care and Use of Experimental Rats and
were approved by the Yale University Institutional Animal Care
and Use Committee.
Corticosterone exposure
A low-dose chronic oral CORT paradigm designed to mimic
the effects of chronic mild stress was adapted from previous studies
[17,18,20,44]. Briefly, corticosterone (4-Pregnen-11b, 21-Diol-3,
20-Dione 21-Hemisuccinate; Steraloids, Inc) solution was made by
dissolving it in tap water, bringing the pH to 12 and stirring for
1 hr. After CORT was in solution, the pH was brought down to
7.0–7.4 using HCl. The CORT solution was made fresh every
72 hours and bottles were weighed daily to measure rats’ fluid
consumption. For experiments examining the acute effects of
chronic CORT exposure, rats received either water alone or
CORT in their drinking water at a concentration of 50 mg/ml for
2 weeks followed by sacrifice. For experiments examining the long-
lasting effects of chronic CORT exposure, rats received CORT in
their drinking water at a concentration of 50 mg/ml for 2 weeks,
followed by 6 days of CORT titration in which the concentration
was reduced to 25 mg/ml for 3 days and then 12.5 mg/ml for an
additional 3 days. Rats then received a ‘wash-out’ period during
which they received access to regular water for 2 weeks. This low-
dose chronic 14 d CORT exposure protocol has been shown to
reliably increase serum CORT levels and to induce in rodent
models a long-lasting phenotype of anhedonia, helplessness-like
behavior and morphological changes in the hippocampus and
prefrontal cortex similar to what has been observed with chronic
behavioral stressors [17,18,20,44,62]. Importantly, it is the chronic
nature of the model that appears to be critical; exposure to this
low-dose oral CORT paradigm for 1 d has not been observed to
promote molecular changes in the brain [19]. Further, unlike
protocols that use higher doses of CORT [32], this protocol has
been shown to be without significant effects on body weight during
the CORT exposure period [18]. Levels of serum CORT have
been observed to rapidly return to baseline following the CORT
exposure period using this protocol [17,18], and no long-term
changes in either body or adrenal weights have been observed
[18]. In our experiments, total fluid intake during the CORT
exposure averaged ,35–40 ml/day (,1.75–2.0 mg CORT/day/
rat), and was not observed to differ significantly between groups
(water vs. CORT; p . 0.05; Figure S1a).
Fluoxetine exposure
For the fluoxetine (FLX) treatment experiments, rats received
exposure to 2 weeks of chronic oral CORT (50 mg/ml) followed by
6 days of CORT titration (25 mg/ml for 3 days; 12.5 mg/ml for 3
days) as described above. Following CORT titration, rats received
a 3 week ‘wash-out’ period during which they were exposed to
either regular water with 2% saccharin or fluoxetine in their
drinking water (333 ml/ml). Fluoxetine hydrochloride (Matrix
Scientific) was dissolved in tap water with 2% saccharin to mask
the taste. Fluoxetine was made fresh weekly. Total fluid intake
during the FLX exposure period averaged ,30 ml/day (,9.9 mg
FLX/day/rat) and did not differ between groups (p . 0.05; Figure
S1b).
Western blotting experiments
To examine the expression of CORT-regulated proteins in the
LA, rats were sacrificed either at the end of the 2 week exposure to
50 mg/ml CORT, the end of the 2 week water ‘wash-out’ period,
or at the end of the 3 week period of treatment with fluoxetine.
Rats were sedated using isoflurane and decapitated. Brains were
frozen and stored at 280uC until processed. For Western blotting,
punches were taken from the LA using a 1 mm punch tool (Fine
Science Tools, Foster City, CA) from 400-mm-thick sections cut on
a sliding freezing microtome. Punches were manually dounced in
100 ml of ice-cold hypotonic lysis buffer [10 mM Tris-HCl,
pH 7.5, 1 mM EDTA, 2.5 mM sodium pyrophosphate, 1 mM
phenylmethylsulfonyl fluoride, 1 mM b-glycerophosphate, 1%
Igepal CA-630, 1% protease inhibitor cocktail (Sigma) and 1 mM
sodium orthovanadate]. Sample buffer was immediately added to
the homogenates, and the samples were boiled for 4 min.
Homogenates were electrophoresed on 4–20% gels and blotted
to Immobilon-P (Millipore, Bedford, MA). Western blots were
blocked in 5% milk in TTBS buffer (50 mM Tris-HCl, pH 7.5,
150 mM NaCl, and 0.05% Tween 20) then incubated with anti-
phospho ERK (1:1K; Cell Signaling), anti-total ERK (1:1K; Cell
Signaling), anti-acetyl histone H3 (1:3K; Millipore), anti-total
histone H3 (1:5K; Millipore), anti-Arc/Arg3.1 (1:1K; Santa Cruz),
anti-Egr-1 (1:1K; Santa Cruz), anti-BDNF (1:600; Millipore), anti-
synaptophysin (1:5K; Dako), or anti-GluR1 (1:1K; Abcam)
Chronic Corticosterone Exposure & Fear Memory
PLOS ONE | www.plosone.org 2 March 2014 | Volume 9 | Issue 3 | e91530
antibody. Blots were then incubated with anti-rabbit or anti-mouse
conjugated to horseradish peroxidase (1:20K; Cell Signaling) and
developed using West Dura chemiluminescent substrate (Pierce).
GAPDH (1:5K; Abcam) was used as a loading control for all
Western blotting experiments. Optical densities of the bands were
analyzed using NIH Image software. For analysis of ERK and
histone H3 proteins, optical densities for total ERK or total H3
were first normalized to GAPDH. Phospho-ERK or acetyl-H3 was
then normalized to total ERK or total H3 for each sample and
expressed as a percentage of that in the water alone control group.
Optical densities for all other proteins were normalized to
GAPDH and expressed as a percentage of the water alone control
group.
Elevated plus maze
Prior to fear conditioning, rats were tested in the elevated plus
maze (EPM) to assess the effect of a history of chronic CORT
exposure and the effects of subsequent FLX treatment on
unlearned fear/anxiety-like responses. The EPM was performed
essentially as previously described [63]. Briefly, each rat was
placed at the center of the maze, and its behavior was recorded
onto videotape for a period of 10 min. The total time each rat
spent in the open arms and the numbers of entries into either the
open or closed arms was recorded across the 10 min period by an
observer blind to experimental conditions. The task was carried
out in a small, dimly lit room (100LUX).
Fear conditioning
Rats were habituated to handling and to the conditioning
chambers for 2 days prior to training. On the training day, rats
were fear conditioned with 2 tone-shock pairings consisting of a 20
sec, 5 kHz, 75 dB tone that co-terminated with a 1 sec, 0.25 mA
foot shock (ITI = 120 sec). Testing for short-term memory (STM)
and long-term memory (LTM) occurred at 2 and 24 hrs following
training, respectively. For each test, rats were placed in a distinct
environment that was dark and consisted of a flat black plastic
floor that had been washed with a peppermint-scented soap. The
STM test consisted of presentation of 3 conditioned stimulus (CS)
tones to minimize extinction. The LTM test consisted of exposure
to 10 CS tones. Freezing behavior, defined as a lack of all
movement with the exception of that required for respiration, was
recorded onto video tape during all testing sessions and scored by
hand by an experimenter who was blind to the experimental
conditions. Freezing to each 20 sec tone was expressed as a
percentage of the total CS presentation time and data were
analyzed with repeated-measures ANOVA. Differences were
considered significant if p , 0.05.
Results
Chronic exposure to CORT enhances the expression of
intracellular signaling pathways, memory-related IEGs
and synaptically-localized proteins in the lateral
amygdala
As an initial step toward asking whether chronic exposure to
CORT might promote alterations in the expression of plasticity-
related proteins the LA that, in turn, regulate the consolidation of
a fear memory, we first examined the expression of memory-
related and synaptically-localized proteins in the LA following 2
weeks of chronic oral CORT exposure. Previous work from our
lab and others has shown that the consolidation of a Pavlovian fear
memory requires phosphorylation of the extracellular signal-
regulated kinase (ERK), the acetylation of histone H3, and the
expression of the immediate-early genes (IEGs) activity-regulated
cytoskeletal-associated protein (Arc/Arg3.1), early growth re-
sponse protein 1 (Egr-1) and BDNF in the LA [33–42]. In this
first experiment, we examined the expression of each of these
memory-related proteins in the LA on the final day of a 2-week
chronic exposure to CORT (Figure 1a). We also examined the
expression of the synaptically-localized proteins GluR1 and
synaptophysin as an assay for whether chronic exposure to CORT
may promote morphological (e.g. spine) changes in the LA that
have previously been observed following exposure to a chronic
behavioral stressor [13,28,29]. For a comparison with previous
work that has documented stress- and CORT-related changes in
neuronal morphology and BDNF expression in the hippocampus
[9–13,21], we also examined the expression of GluR1, synapto-
physin and BDNF in samples from hippocampal area CA3 in the
same animals.
Rats received either plain water or CORT (50 mg/ml) in their
drinking water for 14 consecutive days and were sacrificed on the
last day of CORT exposure (Figure 1a). Western blot analysis from
punches taken from hippocampal area CA3 revealed that a 2 week
exposure to CORT resulted in a significant downregulation of
GluR1 [t(16) = 3.47, p , 0.01], synaptophysin [t(16) = 2.95, p ,
0.01], and BDNF [t(16) = 2.52, p , 0.05] proteins (Figure 1b). In
contrast, and consistent with previous reports of increased
dendritic length and branch points and spine number in LA
neurons following a chronic behavioral stressor [13,28,29], we
observed a significant upregulation in synaptophysin [t(16) = 2.63,
p , 0.05] and GluR1 [t(16) = 2.66, p , 0.05] protein expression in
the LA (Figure 1c). Further, Western blot analysis revealed that
chronic CORT exposure resulted in a significant upregulation of
phospho-ERK1 [t(15) = 2.74, p , 0.05], phospho-ERK2 [t(15) =
3.48, p , 0.01], acetylated histone H3 [t(14) = 3.52, p , 0.05],
Arc/Arg3.1 [t(16) = 2.15, p , 0.05], Egr-1 [t(16) = 2.23, p , 0.05]
and BDNF [t(16) = 2.27, p , 0.05] protein expression in the LA
(Figure 1c). We observed no significant differences in the
expression of total-ERK or total-H3 protein (ERK1: t(15) =
0.40, p . 0.05; ERK2: t(15) = 0.42, p . 0.05; H3: t(14) = 0.78, p
. 0.05) or in the loading control GAPDH between groups in any
of our assays.
Chronic exposure to CORT persistently enhances the
expression of memory-related IEGs and synaptically-
localized proteins in the lateral amygdala
In our next series of experiments, we examined the persistence
of the CORT-related alterations in the expression of synaptically-
localized and memory-related proteins in hippocampal area CA3
and the LA. Rats received chronic exposure to either plain water
or CORT (50 mg/ml) in their drinking water for 14 days, followed
by an additional 6 days of CORT titration (25 mg/ml for 3 days,
12.5 mg/ml for 3 days). Rats then received a ‘wash-out’ period
consisting of exposure to regular water for an additional 2 weeks
prior to sacrifice (Figure 1a).
Consistent with previous findings showing a reversal in stress-
related morphological changes and in the expression of BDNF
mRNA in area CA3 following a recovery period [21,26,27,31], we
observed no significant changes in either GluR1 [t(16) = 0.42, p .
0.05], synaptophysin [t(16) = 0.10, p . 0.05], or BDNF [t(16) =
0.60, p . 0.05] proteins in area CA3 in rats with a history of
chronic CORT exposure (Figure 1e). In contrast, and consistent
with previous findings showing a persistent enhancement in
dendritic length and branch points in the LA following exposure to
a chronic behavioral stressor [27], we observed that rats with a
history of chronic CORT exposure exhibited enhanced expression
of both GluR1 [t(15) = 2.05, p = 0.05] and synaptophysin [t(16) =
Chronic Corticosterone Exposure & Fear Memory
PLOS ONE | www.plosone.org 3 March 2014 | Volume 9 | Issue 3 | e91530
2.24, p , 0.05] in the LA (Figure 1f). Remarkably, we also
observed a persistent increase in the expression of the IEGs Arc/
Arg3.1 [t(15) = 2.20, p , 0.05] and Egr-1 [t(15) = 2.29, p , 0.05]
that was not associated with persistently elevated levels of
phospho-ERK1 [t15) = 0.11, p . 0.05], phospho-ERK2 [t(15)
= 0.21, p . 0.05] or acetyl-H3 [t(15) = 0.39, p . 0.05] protein
expression in the LA (Figure 1f). In contrast to Arc/Arg3.1 and
Egr-1, we observed no persistent increase in the expression of
BDNF protein in the LA (t(16) = 0.71, p . 0.05; Figure 1f). Levels
of total ERK [ERK1: t(15) = 0.10, p . 0.05; ERK2: t(15) = 0.79, p
. 0.05]; total-H3 [t(15) = 0.05, p . 0.05] or the loading control
GAPDH did not differ between groups in any of the experiments.
Collectively, our findings are consistent with those of previous
reports of long-lasting dendritic hypertrophy in the LA following
chronic behavioral stress [13,27]. Further, given that these
experiments were performed two weeks following the last exposure
to CORT, our findings suggest that a history of chronic exposure
to CORT can regulate memory-related IEG expression in the LA
in a long-lasting manner.
Rats with a history of chronic CORT exposure exhibit
enhanced consolidation of a Pavlovian fear memory
In the preceding experiments, we showed that chronic exposure
to CORT elevates the expression of the memory-related IEGs
Arc/Arg3.1 and Egr-1 in the LA, and that the expression of these
proteins remains elevated in a persistent manner long after the
exposure to CORT has ended. Given that both Arc/Arg3.1 and
Egr-1 have been implicated in fear memory consolidation
processes in the LA [33,36], in our next set of experiments we
asked whether a history of chronic exposure to CORT can
enhance the consolidation of a Pavlovian fear memory. Previous
studies using both behavioral stressors and chronic exposure to
oral CORT have observed enhancements in auditory and
contextual fear memory shortly after the stress/CORT exposure
period [31,32], but see [43], findings that are consistent with our
observations that a period of chronic CORT exposure can elevate
the expression of plasticity-related signaling pathways in the LA.
To date, however, few studies have examined whether a history of
chronic stress or oral CORT exposure can modify the acquisition
or consolidation of an amygdala-dependent fear memory.
Figure 1. Chronic exposure to CORT persistently enhances the expression of memory-related IEGs and synaptically-localized
proteins in the LA. (A) Schematic of the behavioral protocol. Rats received either Water or CORT in their drinking water (50 mg/ml) for 2 weeks. Half
the rats were sacrificed at the end of CORT exposure period. The other half was titrated off the CORT (25 mg/ml, 12.5 mg/ml) and given a 2 week
period of exposure to water alone (‘wash-out’) prior to being sacrificed. (B) Mean (6SEM) immunoreactivity for GluR1, synaptophysin and BDNF
(Water: n = 9; CORT: n = 9) from area CA3 in rats sacrificed on the last day of CORT exposure. (C) Mean (6SEM) immunoreactivity for GluR1 (Water:
n = 9; CORT: n = 9), synaptophysin (Water: n = 9; CORT: n = 9), Arc/Arg3.1 (Water: n = 9; CORT: n = 9), Egr-1 (Water: n = 9; CORT: n = 9), BDNF (Water:
n = 9; CORT: n = 9), acetyl-H3 (Water: n = 7; CORT: n = 9), phospho-ERK 1 and phospho-ERK 2 (Water: n = 8; CORT: n = 9) from the LA in rats sacrificed on
the last day of CORT exposure. (D) Representative Western blots for each protein in (C). (E) Mean (6SEM) immunoreactivity for GluR1, synaptophysin,
and BDNF (Water: n = 9; CORT: n = 9) from area CA3 in rats sacrificed on the last day of the wash-out period. (F) Mean (6SEM) immunoreactivity for
GluR1 (Water: n = 9; CORT: n = 8), synaptophysin (Water: n = 9; CORT: n = 9), Arc/Arg3.1 (Water: n = 9; CORT: n = 8), Egr-1 (Water: n = 9; CORT: n = 8),
BDNF (Water: n = 9; CORT: n = 9), acetyl-H3 (Water: n = 9; CORT: n = 8), phospho-ERK 1 and phospho-ERK 2 (Water: n = 9; CORT: n = 8) from the LA in
rats sacrificed on the last day of the wash-out period. (G) Representative Western blots for each protein in (F). For each experiment, protein levels
have been normalized to GAPDH levels for each sample and expressed as a percentage of the Water group. (*) p , 0.05 relative to Water group.
doi:10.1371/journal.pone.0091530.g001
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In our experiments, rats received exposure to either plain
water or CORT (50 mg/ml) in their drinking water for 2
weeks, followed by an additional 6 days of CORT titration
(25 mg/ml for 3 days, 12.5 mg/ml for 3 days) as before. Rats
then received a ‘wash-out’ period for an additional 2 weeks
consisting of exposure to regular water. Following the wash-out
period, all rats were tested in the elevated plus maze (EPM) to
assay the effects of a history of chronic CORT exposure on
unlearned fear/anxiety-like behavior. Following the EPM test,
rats were habituated to the fear conditioning chamber for 2
days followed by fear conditioning consisting of 2 tone-shock
pairings. Short-term and long-term memory tests were
performed 2 and 24 hrs later, respectively, in a distinct context
(Figure 2a).
Consistent with previous reports [18,44], we observed no
significant effects of prior chronic exposure to CORT in the
EPM (Figure 2b). No statistically significant differences were
observed in the total time spent in either the open [t(14) = 1.56,
p . 0.05] or closed [t(14) = 0.26, p . 0.05] arms of the maze
(Figure 2b). Further, we observed no significant differences in
the total number of entries into the open [t(14) = 1.45, p . 0.05]
or closed [t(14) = 1.46, p . 0.05] arms of the maze (data not
shown).
In our fear conditioning experiments, we observed no differ-
ences in post-shock freezing (PSF) during training (Figure 2c). The
ANOVA for PSF scores revealed nonsignificant effects for group
[F(1,14) = 0.07, p . 0.05] and the group by trial interaction [F(2,28)
= 0.70, p . 0.05], but a significant effect for trial [F(2,28) = 45.03,
p , 0.001]. Further, water and CORT-treated rats exhibited
comparable levels of freezing during the STM test (Figure 2d). The
ANOVA for STM scores revealed nonsignificant effects for group
[F(1,14) = 0.27, p . 0.05], trial [F(2,28) = 2.04, p . 0.05], and the
group by trial interaction [F(2,28) = 0.20, p . 0.05]. Therefore, a
history of chronic CORT exposure does not interfere with shock
sensitivity (as assayed by PSF) or the acquisition or short-term
storage of an auditory fear memory. During the LTM test,
however, rats with a history of chronic CORT exposure exhibited
a significantly higher level of fear memory retention relative to
water controls (Figure 2e). The ANOVA for LTM scores revealed
significant effects for group [F(1,14) = 31.65 p , 0.001] and trial
[F(9,126) = 5.66, p , 0.001], and a nonsignificant group by trial
interaction [F(9,126) = 0.65, p . 0.05].
Collectively, our findings suggest that a prior history of chronic
oral CORT exposure is able to enhance not only the expression of
memory-related IEGs in the LA in a persistent manner, but also
the consolidation of an auditory Pavlovian fear memory; that is,
LTM is enhanced, while STM is unaffected.
Figure 2. A history of chronic CORT exposure enhances the consolidation of a Pavlovian fear memory. (A) Schematic of the behavioral
protocol. Rats received either Water (n = 7) or CORT (n = 9; 50 mg/ml) for 2 weeks followed by CORT titration (25 mg/ml, 12.5 mg/ml) and a 2 week
water ‘wash-out’ period. At the end of the wash-out period, rats were tested in the elevated plus maze (EPM). Rats were then fear conditioned with 2
tone-shock pairings and tested for STM (2 hr later) and LTM (24 hr later). (B) Mean (6SEM) time spent exploring the open and closed arms of the EPM
in each group. (C) Mean (6SEM) post-shock freezing scores in each group following each conditioning trial. (D) Mean (6SEM) STM scores across each
trial in each group. (E) Mean (6SEM) LTM scores across each trial in each group.
doi:10.1371/journal.pone.0091530.g002
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Fluoxetine treatment following chronic CORT exposure
reverses the persistent enhancement in memory-related
IEG expression in the LA
Previous work has shown that treatment with the SSRI
fluoxetine following a period of chronic oral CORT exposure
can normalize CORT-related molecular changes in the hippo-
campus [18]. In our next series of experiments, we asked whether
treatment with fluoxetine can reverse the effects of a history of
chronic CORT on the persistent expression of memory-related
IEGs and synaptically-localized proteins in the LA. Rats received
either plain water or chronic exposure to CORT (50 mg/ml) in
their drinking water for 2 weeks followed by 6 days of CORT
titration (25 mg/ml for 3 days, 12.5 mg/ml for 3 days) as before.
Following CORT titration, each group was divided into two
additional groups that received either plain water or fluoxetine
(FLX; 333 mg/ml) in their drinking water for an additional 3
weeks resulting in the following 4 groups: Water/Water, Water/
FLX, CORT/Water, CORT/FLX. On the last day of water or
fluoxetine treatment, rats were sacrificed and brains were
processed for protein analysis (Figure 3a).
Consistent with our previous findings, Western blot analysis
revealed that a prior chronic exposure to CORT led to significant
elevations in the expression of Arc/Arg3.1, Egr-1, GluR1 and
synaptophysin in the LA (Water/Water vs. CORT/water groups;
Figure 3b). Remarkably, a 3 week treatment with FLX was
observed to reverse the effects of CORT on memory-related IEG
expression in the LA (CORT/Water vs. CORT/FLX groups;
Figure 3b). The ANOVAs for the IEGs revealed a significant effect
for group [Arc/Arg3.1: F(3,27) = 3.11, p , 0.05; Egr-1: F(3,28) =
4.97, p , 0.01], with the CORT/Water groups differing
significantly from Water/Water, Water/FLX, and CORT/FLX
groups (p , 0.05; Duncan’s test). Treatment with FLX alone
(Water/Water vs. Water/FLX) was observed to have no effect on
IEG expression in the LA (p . 0.05).
Interestingly, treatment with FLX was observed to have no
effect on the persistent enhancement of either GluR1 or
synaptophysin the LA (Figure 3c). The ANOVAs for the
synaptically-localized proteins revealed a significant effect for
group [GluR1: F(3,28) = 3.61, p , 0.05; synaptophysin: F(3,28) =
3.88, p , 0.05]. Duncan’s post-hoc t-tests revealed significant
differences between the CORT/Water and CORT/FLX groups
relative to the Water/Water and Water/FLX groups (p , 0.05),
while treatment with FLX alone (Water/Water vs. Water/FLX)
was found to have no effect (p . 0.05). No significant difference
between the CORT/Water and CORT/FLX groups was
observed (p . 0.05).
Collectively, our findings indicate that chronic treatment with
the SSRI fluoxetine following a period of chronic CORT exposure
can effectively reverse the persistent CORT-induced changes in
memory-related IEG expression in the LA.
Figure 3. Fluoxetine treatment following chronic CORT exposure reverses the persistent enhancement in memory-related IEG
expression in the LA. (A) Schematic of the behavioral protocol. Rats received either Water or CORT (50 mg/ml) for 2 weeks followed by CORT
titration (25 mg/ml, 12.5 mg/ml). Rats then received 3 weeks of either Water or fluoxetine (FLX; 333 mg/ml) and were then sacrificed. (B) Mean (6SEM)
immunoreactivity for Arc/Arg3.1 (Water/Water: n = 8; Water/Flx: n = 8; CORT/Water: n = 8; CORT/Flx: n = 7) and Egr-1 (Water/Water: n = 8; Water/Flx:
n = 8; CORT/Water: n = 8; CORT/Flx: n = 8) in the LA for each group. (C) Mean (6SEM) immunoreactivity for GluR1 and synaptophysin (Water/Water:
n = 8; Water/Flx: n = 8; CORT/Water: n = 8; CORT/Flx: n = 8) in the LA for each group. Representative Western blots for all proteins are shown in the
inset. For each experiment, protein levels have been normalized to GAPDH levels for each sample and expressed as a percentage of the Water/Water
group. (*) p , 0.05 relative to Water/Water group.
doi:10.1371/journal.pone.0091530.g003
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Fluoxetine treatment following chronic CORT exposure
reverses the CORT-induced enhancement of fear
memory consolidation
In our final experiment, we asked whether fluoxetine treatment
following a history of chronic oral CORT exposure is capable of
reversing the CORT-related enhancement in fear memory
consolidation. Rats received either plain water or chronic exposure
to CORT (50 mg/ml) in their drinking water for 2 weeks followed
by CORT titration (25 mg/ml for 3 days, 12.5 mg/ml for 3 days)
and an additional 3 weeks of treatment with either water or
fluoxetine (333 mg/ml) as above. Following the FLX treatment
period, rats in each of the 4 groups were tested in the EPM to
assay the effects of CORT and FLX on unlearned fear/anxiety-
like responses. Rats were then habituated to the conditioning
chamber for 2 days prior to fear conditioning consisting of 2 tone-
shock pairings and tested for both STM (at 2 hr) and LTM (at
24 hr) in a distinct context as before (Figure 4a). All rats remained
on their respective treatment (water or FLX) throughout the
duration of the behavioral experiments.
Similar to our findings above, we observed no significant effects
of a prior chronic exposure to CORT in the EPM. We also
observed that treatment with this dose of FLX alone had no
significant effect on rats’ performance in the EPM (Figure 4b). No
statistically significant differences between groups were observed in
the total time spent in either the open [F(3,22) = 2.02, p . 0.05] or
closed [F(3,22) = 2.06, p . 0.05] arms of the maze (Figure 4b).
Further, we observed no significant differences in the total number
of entries into the open [F(3,22) = 2.15, p . 0.05] or closed [F(3,22)
= 1.49, p . 0.05] arms of the maze (data not shown).
In our fear conditioning experiments, we observed no differ-
ences in post-shock freezing during training among the 4 groups
(Figure 4c). The ANOVA for PSF scores revealed a significant
effect for trial [F(2,46) = 214.09, p , 0.001], but nonsignificant
effects for group [F(3,23) = 0.09, p . 0.05] and the group by trial
interaction [F(6,46) = 0.08, p . 0.05]. Further, each of the 4
groups exhibited comparable levels of freezing during the STM
test (Figure 4d). The ANOVA for STM scores revealed
nonsignificant effects for group [F(3,23) = 0.54, p . 0.05], trial
[F(2,46) = 2.86, p . 0.05], and the group by trial interaction
[F(6,46) = 0.40, p . 0.05]. During the LTM test, however, the
CORT/Water group demonstrated significantly higher levels of
fear memory retention relative to all other groups (p , 0.05;
Duncan’s test; Figure 4e). The ANOVA for LTM scores revealed
significant effects for group [F(3,23) = 7.63, p , 0.01] and trial
[F(9,207) = 2.50, p , 0.001], but a nonsignificant group by trial
interaction [F(27,207) = 0.21, p . 0.05]. Importantly, there was no
effect of this dose of FLX alone on the expression of fear memory
in the Water/FLX group (p . 0.05).
Collectively, these findings indicate that treatment with the
SSRI fluoxetine following a period of chronic oral CORT
exposure can reverse not only the persistent elevation in
Figure 4. Fluoxetine treatment following chronic CORT exposure reverses the CORT-induced enhancement of fear memory
consolidation. (A) Schematic of the behavioral protocol. Rats received either Water (n = 7) or CORT (n = 7; 50 mg/ml) for 2 weeks followed by CORT
titration (25 mg/ml, 12.5 mg/ml). Rats then received 3 weeks of either Water (n = 6) or fluoxetine (FLX; n = 7; 333 mg/ml). At the end of the fluoxetine
exposure period, rats were tested in the elevated plus maze (EPM). Rats were then fear conditioned with 2 tone-shock pairings and tested for STM
(2 hr later) and LTM (24 hr later). (B) Mean (6SEM) time spent exploring the open and closed arms of the EPM in each group. (C) Mean (6SEM) post-
shock freezing scores in each group following each conditioning trial. (D) Mean (6SEM) STM scores across each trial in each group. (E) Mean (6SEM)
LTM scores across each trial in each group.
doi:10.1371/journal.pone.0091530.g004
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memory-related IEG expression in the LA, but also the CORT-
related enhancement in fear memory consolidation.
Discussion
The effects of chronic stress and oral CORT administration
have been widely studied at the behavioral, morphological and
molecular levels, particularly in the hippocampus [9,10,12,13,17–
20,23–26,31]. More recent work has focused on examining the
effects of chronic behavioral stress in the amygdala, where long-
lasting alterations in anxiety-like behavior and in the morphology
of LA neurons have been observed [13,21,27–30]. While exposure
to chronic stress or oral CORT have each been shown to enhance
amygdala-dependent fear memory shortly after the stress/CORT
period [31,32], few studies have to date examined the long-lasting
effects of a history of chronic stress or oral CORT on plasticity-
related signaling pathways in the LA and amygdala-dependent
memory processes. In the present study, we examined the long-
lasting molecular and behavioral consequences of prior chronic
oral CORT exposure, a pharmacological model of chronic stress
with construct, face and predictive validity [17–20]. We found that
a history of chronic oral CORT exposure leads to a persistent
elevation in the expression of memory-related IEGs in the LA and
to enhanced consolidation of an amygdala-dependent Pavlovian
fear memory. Further, we show that each of these effects can be
reversed by treatment with the SSRI fluoxetine.
In the hippocampus, the effects of chronic stress and oral
CORT exposure have consistently been observed to promote
dendritic atrophy [9–13] and a downregulation of memory-related
signaling pathways and genes, including that of phosphorylated
ERK, phosphorylated CREB and BDNF [17–21]. Consistent with
these findings, we show that a 2-week exposure to oral CORT
produces a downregulation in the expression of BDNF and the
synaptically-localized proteins GluR1 and synaptophysin in
hippocampal area CA3. Interestingly, while stress-induced mor-
phological changes in the hippocampus have largely been
observed to be transient [27,31], the molecular changes have
been observed to persist after a recovery period in some [17–20],
but not all [21], studies. In our own experiments, we observed that
the CORT-related downregulation in the expression of GluR1,
synaptophysin, and BDNF in hippocampal area CA3 was
transient. In the amygdala, we observed that chronic exposure
to oral CORT promotes an upregulation of phosphorylated ERK,
acetylated histone H3, and the expression of the IEGs Arc/Arg3.1,
Egr-1 and BDNF in LA neurons. Consistent with previous work
that has observed long-lasting dendritic hypertrophy in the LA
following chronic behavioral stress [13,27–29], these molecular
changes were paralleled by an increase in the expression of the
synaptically-localized proteins GluR1 and synaptophysin in the
LA that persisted following the recovery period. Remarkably,
while the CORT-induced enhancement in the expression of
phospho-ERK and acetyl-H3 was observed to return to baseline
levels following recovery from CORT exposure, the enhanced
expression of the memory-related IEGs Arc/Arg3.1 and Egr-1 was
observed to persist.
At the behavioral level, we observed that the consolidation of
auditory Pavlovian fear conditioning was also enhanced by prior
chronic oral CORT exposure; LTM was enhanced, whereas post-
shock freezing and STM were unaffected. The finding that post-
shock freezing and STM were unaffected makes it unlikely that
our behavioral effects were due to altered tone or shock processing
at the time of fear acquisition. Further, consistent with previous
observations [18,44], we observed no significant effect of prior
chronic CORT exposure on unlearned fear/anxiety-like behavior.
Collectively, our findings suggest that chronic oral CORT
exposure can regulate the expression of memory-related IEGs in
the LA in a long-lasting manner and promote enhanced
consolidation of a Pavlovian fear memory acquired long after
the CORT exposure period has ended. Notably, a related study
using the same oral CORT exposure protocol found no significant
effects on fear memory consolidation using a contextual fear
conditioning paradigm [44]. However, contextual fear condition-
ing depends on both the amygdala and the hippocampus [45–47].
Thus, it is likely that enhanced and impaired consolidation
processes at the level of the amygdala and hippocampus,
respectively, driven by potentially opposing molecular alterations,
may mask CORT-induced alterations in contextual fear memory
consolidation [44]. In the present study, the use of an auditory fear
conditioning paradigm may have allowed us to selectively observe
a CORT-induced enhancement of amygdala-dependent fear
memory consolidation.
What is the mechanism by which oral CORT persistently
upregulates the expression of memory-related IEGs in the LA?
One attractive hypothesis is that chronic CORT exposure
promotes epigenetic alterations on memory-related genes in LA
neurons, which result in long-lasting changes in the manner in
which these genes are expressed. Epigenetic modifications,
including alterations in chromatin structure and DNA methyla-
tion, have been widely implicated in memory and cognition and in
brain regions associated with drug addiction and chronic stress,
where they produce persistent alterations in gene expression that
promote long-lasting behavioral phenotypes [48–51]. Chronic
social defeat stress, for example, has been shown to promote
significant increases in histone H3-K27 dimethylation, a repressive
histone modification, on the promoters of BDNF transcripts III
and IV [52]. In the nucleus accumbens (NAcc), chronic social
defeat has been shown to significantly decrease the expression of
histone deacetylase (HDAC) subtype 5, and mice that lack
HDAC5 have been observed to exhibit enhanced depressive and
anxiety-like behaviors [53]. Further, exposure to chronic social
stress has been observed to lead to an increase in DNA
methyltransferase (DNMT) subtype 3A mRNA expression in the
NAcc, and virally-mediated overexpression DNMT3A in the
NAcc has been shown to promote pro-depressive and anxiety-like
behaviors [54]. These observations suggest that chronic stress can
modify the chromatin structure and methylation patterns of genes
in a regionally specific and persistent manner, which may in turn
promote long-lasting behavioral phenotypes. Future studies will be
required to examine epigenetic modifications in memory-related
genes in the LA, including Arc/Arg3.1 and Egr-1, following
chronic oral CORT exposure.
In our experiments, we observed that chronic treatment with
the SSRI fluoxetine reversed both the persistent elevation in
memory-related IEG expression in the LA and the enhanced
consolidation of a fear memory in CORT-exposed rats. Fluoxetine
is one of the most widely prescribed SSRIs for the treatment of a
range of anxiety disorders, including PTSD [55-57], and
accumulating evidence from animal models has suggested that
treatment with SSRIs may be a useful therapeutic tool for the
treatment of persistent and reoccurring traumatic memories [58–
60]. In our experiments, we observed no effect of FLX alone (at
this dose and route of administration) on memory-related gene
expression in the LA and on fear memory acquisition or
consolidation; FLX was only observed to reverse the enhancement
of memory-related IEG expression in the LA and fear memory
consolidation in rats exposed to chronic CORT. Notably, we
observed no effect of FLX on the persistent CORT-induced
increases in the synaptically-localized proteins GluR1 and
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synaptophysin in the LA. This finding is relevant in light of work
suggesting that treatment with the atypical antidepressant (ADT)
tianeptine during a period of chronic stress can prevent the stress-
induced morphological changes in both hippocampal area CA3
and the LA [31,61], while having no effect on the stress-induced
enhancement of fear conditioning [31]. Together with our
findings, these observations suggest that persistent morphological
changes in the LA that are induced by chronic stress or oral
CORT may not be casually related to enhanced memory
formation and/or consolidation.
The mechanism by which FLX reverses CORT-related
enhancements in fear memory consolidation and memory-related
gene expression in the LA remains unknown, but may be related
to the targeting of epigenetic processes in the LA. For example,
chronic treatment with the ADT imipramine significantly
decreases the expression of HDAC5 mRNA in the hippocampus
and promotes a hyperacetylation of histone H3 on the promoter
region of BDNF transcripts III and IV [52], providing a potential
pro-transcriptional mechanism by which to counter the persistent
dimethylation of histone H3-K27 on these BDNF transcripts. In
contrast, chronic treatment with imipramine has been shown to
lead to increased expression of HDAC5 in the NAcc [53]. These
observations suggest that ADTs can promote epigenetic alterations
on plasticity-related genes that compensate for the stress-related
alterations in chromatin structure and DNA methylation. Future
experiments will be necessary to examine the role of epigenetic
mechanisms in the effects of FLX in the LA.
In summary, the findings of the present study suggest that a
history of chronic stress, as modeled by a chronic oral exposure to
CORT, can enhance fear memory consolidation processes
and regulate memory-related IEG gene expression in the LA in
a long-lasting manner, and that treatment with the SSRI
fluoxetine can reverse these effects. The chronic oral CORT
paradigm represents a useful animal model for investigation of
amygdalar-regulated stress mechanisms that should help us to
better understand the development of anxiety disorders such as
PTSD that are characterized by unusually strong and persistent
fear memories.
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